NCT02831517View on ClinicalTrials.gov

PK and Safety Study of BIIB074 in Healthy Japanese and Caucasian Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

February 28, 2017

Study Completion Date

February 28, 2017

Conditions
HealthyTrigeminal Neuralgia
Interventions
DRUG

BIIB074

Administered as specified in the treatment arm

DRUG

Placebo

Matched Placebo

Trial Locations (1)

LS2 9LH

Research Site, Leeds

Sponsors

Lead Sponsor

Biogen
All Listed Sponsors
lead

Biogen

INDUSTRY